Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,397 across all filing types
Latest filing 2023-12-11 Report Publication Anno…
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Report Publication Announcement 2023
Report Publication Announcement Classification · 100% confidence The document is titled "Preliminary announcement of the publication of financial reports..." and explicitly states that it is announcing when and where certain financial reports (specifically a 'Financial report of the group (half-year/Q2)') will be disclosed on a future date (July 31, 2024). This structure—announcing the future release of a report rather than containing the report itself—fits the definition of a Report Publication Announcement (RPA). The document length is short (1990 chars), further supporting the 'MENU VS MEAL' rule, which dictates classifying announcements of reports as RPA instead of the report type (like IR).
2023-12-11 English
Report Publication Announcement 2023
Report Publication Announcement Classification · 100% confidence The document is titled "Preliminary announcement of the publication of quarterly reports and quarterly/interim statements." It explicitly states that it is an announcement regarding *when* and *where* future financial reports (Q1 and Q3 reports) will be disclosed, providing future dates and links. This fits the definition of a Report Publication Announcement (RPA), which covers announcements about the timing or release of other company reports, rather than being the report itself (like an IR or 10-K). The document length is short (2355 chars), further supporting the RPA classification over the comprehensive report classification.
2023-12-11 English
Report Publication Announcement 2023
Report Publication Announcement Classification · 100% confidence The document is titled "Preliminary announcement of the publication of financial reports..." and explicitly states that it is announcing *when* and *where* the Annual financial reports (which would typically be 10-K or IR) will be disclosed on a future date (March 14, 2024). This fits the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports, especially given the short length and the nature of the content being a notice rather than the report itself. It is not the actual Annual Report (10-K) or Interim Report (IR).
2023-12-11 English
Fresenius SE & Co. KGaA: Fresenius retains relief payments for hospitals of up to 300 million (from the current perspective) and is therefore subject to a ban on dividends and bonuses for 2023
Notice of Dividend Amount Classification · 99% confidence The document is an 'Ad-hoc' announcement dated December 5, 2023, disclosing 'Inside Information' according to Article 17 MAR. The core content discusses the decision to retain government relief payments, which directly results in a statutory prohibition on paying dividends and bonuses for the financial year 2023. This is a material corporate event announcement concerning capital structure/distribution policy, but it is not a formal report (like 10-K or IR) nor is it solely about management changes (MANG) or director trades (DIRS). Since it announces a significant financial decision impacting shareholder returns (dividend ban) and is released as an immediate regulatory disclosure (MAR 17), it fits best under Capital/Financing Update (CAP) as it directly relates to capital management and distribution policy, or potentially Regulatory Filings (RNS) as a general disclosure. Given the specific nature of the dividend/bonus ban tied to retaining funds, CAP is a strong fit, but because it is a mandatory, immediate disclosure under EU regulation (MAR 17) that doesn't fit the other specific financial report types, RNS (Regulatory Filings) serves as the most appropriate general regulatory disclosure category for such immediate, non-standard announcements, especially since the document itself is short and serves as a notification rather than a detailed report.
2023-12-05 English
Declaration of Conformity of Fresenius SE & Co. KGaA as of December 2023
Governance Information Classification · 99% confidence The document is explicitly titled as a 'Declaration by the Management Board... and by the Supervisory Board... on the German Corporate Governance Code pursuant to Section 161 German Stock Corporation Act'. This document details compliance, or non-compliance (specifically regarding 'overboarding' under Code recommendation C.5), with the German Corporate Governance Code. This content directly relates to the company's internal rules, board structure, and governance practices, making it a Governance Information document.
2023-12-01 English
Entsprechenserklärung der Fresenius SE & Co. KGaA vom Dezember 2023
Governance Information Classification · 99% confidence The document is titled "Erklärung des Vorstands der persönlich haftenden Gesellschafterin der Fresenius SE & Co. KGaA, der Fresenius Management SE, und des Aufsichtsrats der Fresenius SE & Co. KGaA zum Deutschen Corporate Governance Kodex gemäß § 161 AktG". This explicitly states it is a declaration regarding the German Corporate Governance Code (DCGK). This type of declaration, detailing compliance or deviations from governance recommendations, falls directly under the category of Governance Information. The specific mention of 'Kodex-Empfehlung C.5: Schutz vor Overboarding' and the detailed explanation of deviations confirms this classification. This aligns perfectly with the definition for Governance Information (CGR).
2023-12-01 German

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.